252 related articles for article (PubMed ID: 2952831)
41. Brain natriuretic peptide (BNP) gene expression in the heart of vasopressin-deficient Brattleboro rats.
Arjamaa O; Taskinen T; Vuolteenaho O; Leppäluoto J
Acta Physiol Scand; 1997 Mar; 159(3):257-60. PubMed ID: 9079157
[TBL] [Abstract][Full Text] [Related]
42. Osmoregulation and vasopressin secretion during pregnancy in Brattleboro rats.
Barron WM; Dürr J; Stamoutsos BA; Lindheimer MD
Am J Physiol; 1985 Jan; 248(1 Pt 2):R29-37. PubMed ID: 3970184
[TBL] [Abstract][Full Text] [Related]
43. Effect of vasopressin on cardiovascular and renal functions and ANP release under plasma volume expansion.
Ohta M; Kimura T; Ota K; Shoji M; Inoue M; Sato K; Yamamoto T; Yoshinaga K
Tohoku J Exp Med; 1991 Oct; 165(2):115-29. PubMed ID: 1839872
[TBL] [Abstract][Full Text] [Related]
44. [Altered alpha atrial natriuretic peptide (ANP) concentrations in plasma, atria and hypothalamus in experimentally induced hyper- and hypothyroid rats].
Muramatsu H; Suzuki Y; Tsuchiya T; Ohtake R; Hashigami Y; Kobori H; Horikoshi K; Suzuki H; Shimoda S
Nihon Naibunpi Gakkai Zasshi; 1990 Mar; 66(3):168-74. PubMed ID: 2140799
[TBL] [Abstract][Full Text] [Related]
45. The effect of medetomidine, an alpha 2-adrenoceptor agonist, on plasma atrial natriuretic peptide levels, haemodynamics and renal excretory function in spontaneously hypertensive and Wistar-Kyoto rats.
Ruskoaho H; Leppäluoto J
Br J Pharmacol; 1989 May; 97(1):125-32. PubMed ID: 2566350
[TBL] [Abstract][Full Text] [Related]
46. Role of nitric oxide on cardiac hormone secretion: effect of NG-nitro-L-arginine methyl ester on atrial natriuretic peptide and brain natriuretic peptide release.
Leskinen H; Vuolteenaho O; Leppäluoto J; Ruskoaho H
Endocrinology; 1995 Mar; 136(3):1241-9. PubMed ID: 7867578
[TBL] [Abstract][Full Text] [Related]
47. Plasma and atrial levels of atrial natriuretic peptide (ANP) in pulmonary hypertensive rats.
Akimoto K; Miyata A; Hayakawa K; Kangawa K; Matsuo H
Life Sci; 1988; 43(14):1125-32. PubMed ID: 2971849
[TBL] [Abstract][Full Text] [Related]
48. Immunoreactive atrial natriuretic peptide in ventricles, atria, hypothalamus, and plasma of genetically hypertensive rats.
Ruskoaho H; Leppäluoto J
Circ Res; 1988 Feb; 62(2):384-94. PubMed ID: 2962785
[TBL] [Abstract][Full Text] [Related]
49. High, vasopressin-reversible, immunoreactive somatostatin in specific hypothalamic nuclei of rats with diabetes insipidus (Brattleboro rats).
Saavedra JM; Rougeot C; Chevillard C; Dray F
Brain Res; 1983 Oct; 277(1):23-30. PubMed ID: 6139144
[TBL] [Abstract][Full Text] [Related]
50. Central effects of antiserum against human atrial natriuretic polypeptide on water and electrolyte metabolism and plasma arginine-8-vasopressin level in conscious rats.
Laczi F; Szabó G; Jójárt I; Vecsernyés M; Csáti S; Kovács GL; Szarvas F; Telegdy G
Neuropeptides; 1991 Jul; 19(3):183-7. PubMed ID: 1832749
[TBL] [Abstract][Full Text] [Related]
51. Salt overload does not modify plasma atrial natriuretic peptide or vasopressin during pregnancy in rats.
Carvalho EG; Franci CR; Antunes-Rodrigues J; Gutkowska J; Favaretto AL
Exp Physiol; 1998 Jul; 83(4):503-11. PubMed ID: 9717072
[TBL] [Abstract][Full Text] [Related]
52. Sympathetic nervous system and blood pressure maintenance in the Brattleboro DI rat.
Williams JL; Johnson MD
Am J Physiol; 1986 May; 250(5 Pt 2):R770-5. PubMed ID: 2871766
[TBL] [Abstract][Full Text] [Related]
53. Rebound increase in plasma renin and vasopressin following graded infusions of atrial natriuretic peptide in man.
Williams TD; Walsh KP; Pitts E; Sutton R; Lightman SL
J Endocrinol Invest; 1988 Jan; 11(1):31-5. PubMed ID: 2966190
[TBL] [Abstract][Full Text] [Related]
54. The roles of GABA in the central regulation of AVP and ANP release and blood pressure in hypertonic saline infusion and hemorrhage.
Kimura T; Yamamoto T; Ota K; Shoji M; Inoue M; Ohta M; Sato K; Funyu T; Abe K
J Auton Nerv Syst; 1993 May; 43(2):171-8. PubMed ID: 8326097
[TBL] [Abstract][Full Text] [Related]
55. ANP and BNP responses to dehydration in the one-humped camel and effects of blocking the renin-angiotensin system.
Adem A; Al Haj M; Benedict S; Yasin J; Nagelkerke N; Nyberg F; Yandle TG; Frampton CM; Lewis LK; Nicholls MG; Kazzam E
PLoS One; 2013; 8(3):e57806. PubMed ID: 23516417
[TBL] [Abstract][Full Text] [Related]
56. Effects of prolonged vasopressin treatment in Brattleboro rats with diabetes insipidus.
Möhring J; Kohrs G; Möhring B; Petri M; Homsy E; Haack D
Am J Physiol; 1978 Feb; 234(2):F106-11. PubMed ID: 623299
[TBL] [Abstract][Full Text] [Related]
57. Atrial natriuretic peptide and vasopressin in human plasma.
Sakamoto M; Tanaka I; Oki Y; Ikeda Y; Nanno M; Yoshimi T
Peptides; 1988; 9(1):187-91. PubMed ID: 2966344
[TBL] [Abstract][Full Text] [Related]
58. Atrial natriuretic peptide and vasopressin during percutaneous transvenous mitral valvuloplasty and relation to renin-angiotensin-aldosterone system and renal function.
Tsai RC; Yamaji T; Ishibashi M; Takaku F; Fu M; Cherng WJ; Inoue K; Hung JS
Am J Cardiol; 1990 Apr; 65(13):882-6. PubMed ID: 2138848
[TBL] [Abstract][Full Text] [Related]
59. Time course of release of atrial natriuretic peptide in the anaesthetized dog.
Ledsome JR; Wilson N; Rankin AJ; Courneya CA
Can J Physiol Pharmacol; 1986 Jul; 64(7):1017-22. PubMed ID: 2945629
[TBL] [Abstract][Full Text] [Related]
60. The involvement of vasopressin in the renal actions of atrial natriuretic peptide in conscious fluid-balanced rats.
Burgess WJ; Balment RJ
J Endocrinol; 1993 Sep; 138(3):413-20. PubMed ID: 8277217
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
